cGMP inhibits IP3-induced Ca2+ release in intact rat megakaryocytes via cGMP- and cAMP-dependent protein kinases

Journal of Physiology

Volumn 512, Issue 1, 1998, Pages 89-96

  Tertyshnikova, Svetlana ^a,c   Yan, Xiongwei ^b   Fein, Alan ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DERIVATIVE; INOSITOL 1,4,5 TRISPHOSPHATE; LINSIDOMINE; NITROPRUSSIDE SODIUM; 3 MORPHOLINO SYDNONIMINE; 3-MORPHOLINO-SYDNONIMINE; 8 ((4 CHLOROPHENYL)THIO)CYCLIC 3',5' GMP; 8-((4-CHLOROPHENYL)THIO)CYCLIC-3',5'-GMP; CALCIUM; DRUG DERIVATIVE; ENZYME INHIBITOR; MOLSIDOMINE; NITRIC OXIDE DONOR; NUCLEOTIDE; 8 (4 CHLOROPHENYLTHIO) CYCLIC GMP; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; MEGAKARYOCYTE; NONHUMAN; OSCILLATION; PHOTOLYSIS; PRIORITY JOURNAL; RAT; SECOND MESSENGER; ANIMAL; BIOLOGICAL MODEL; BONE MARROW CELL; CYTOLOGY; DRUG EFFECT; IN VITRO STUDY; KINETICS; METABOLISM; WISTAR RAT; ADULT; ENZYME INHIBITION;

ANIMALS; BONE MARROW CELLS; CALCIUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; INOSITOL 1,4,5-TRISPHOSPHATE; KINETICS; MEGAKARYOCYTES; MODELS, BIOLOGICAL; MOLSIDOMINE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHOTOLYSIS; RATS; RATS, WISTAR; SECOND MESSENGER SYSTEMS; THIONUCLEOTIDES;

EID: 0032190626     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-7793.1998.089bf.x     Document Type: Article

References (40)

1. ADAMS, S. R. & TSIEN, R. Y. (1993). Controlling cell chemistry with caged compounds. Annual Review of Physiology 55, 755-784.
2. ALIOUA, A., HUGGINS, J. P. & ROUSSEAU, E. (1995). PKG-1a phosphoryalates the α-subunit and upregulates reconstituted GKCa channels from tracheal smooth muscle. American Journal of Physiology 268, L1057-1063.
3. BEAVO, J. A. (1995). Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiological Reviews 75, 725-748.
4. BOWEN, R. & HASLAM, R. J. (1991). Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role of cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1. Journal of Cardiovascular Pharmacology 17, 424-433.
5. BUECHLER, W. A., IVANOVA, K., WOLFRAM, G., DRUMMER, C, HEIM, J.-M. & GERZER, R. (1994). Soluble guanylyl cyclase and platelet function. Annals of the New York Academy of Sciences 714, 151-157.
6. BUTT, E., NOLTE, C., SCHULZ, S., BELTMAN, J., BEAVO, J. A., JASTORPF, B. & WALTER, U. (1992). Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochemical Pharmacology 43, 2591-2600.
7. CAVALLINI, L., COASSIN, M., BOREAN, A. & ALEXANDRE, A. (1996). Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. Journal of Biological Chemistry 271, 5545-5551.
8. CHENG, H. C., KEMP, B. E., PEARSON, R. B., SMITH, A. J., MISCONI.L., VAN PATTEN, S. M. & WALSH, D. A. (1986). A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. Journal of Biological Chemistry 261, 989-992.
9. 2+: a story with a complex past and a promising future. Trends in Pharmacological Sciences 18, 266-269.
10. CORNWELL, T. L., PRYZWANSKY, K. B., WYATT, T. A. & LINCOLN, T. M. (1991). Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Molecular Pharmacology 40, 923-931.
11. DEANA, R., RUZZENE, M., DONI, M. G., ZOCCARATO, F. & ALEXANDRE, A. (1989). Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate. Biochimica et Biophysica Acta 1014, 203-206.
12. DE CATERINA, R., GIANNESSI, D., BERNINI, W. & MAZZONE, A. (1988). Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Thrombosis and Haemostasis 59, 207-211.
13. EL-DAHER, S. S., EIGENTHALER, M., WALTER, U., FURUICHI, T., MIYAWAKI, A., MIKOSHIBA, K., KAKKAR, V. V. & AUTHI, K. S. (1996). Distribution and activation of cAMP- and cGMP-dependent protein kinases in highly purified human platelet plasma and intracellular membranes. Thrombosis and Haemostatis 76, 1063-1071.
14. FEELISCH, M. & STAMLER, J. S. (1996). Donors of nitrogen oxides. In Methods in Nitric Oxide Research, ed. FEELISCH, M. & STAMLER, J. S., pp. 71-115. John Wiley & Sons Ltd, New York.
15. FERRIS, C. D., CAMERON, A. M., BREDT, D. S., HUGANIR, R. L. & SNYDER, S. H. (1991). Inositol 1,4,5-trisphosphate receptor is phosphorylated by cAMP-dependent protein kinase at serines 1755 and 1589. Biochemical and Biophysical Research Communications 175, 192-198.
16. GEIGER, J., NOLTE, C., BUTT, E., SAGE, S. O. & WALTER, U. (1992). Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proceedings of the National Academy of Sciences of the USA 89, 1031-1035.
17. HIRATA, M., KOHSE, K. P., CHANG, C.-H., IKEBE, T. & MURAD, F. (1990). Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. Journal of Biological Chemistry 265, 1268-1273.
18. JOHANSSON, J. S. & HAYNES, D. H. (1992). Cyclic cGMP increases the rate of the calcium extrusion pump in intact human platelets but has no direct effect on the dense tubular calcium accumulation system. Biochimica et Biophysica Acta 1105, 40-50.
19. KARCZEWSKI, P., KELM, M., HARTMANN, M. & SCHRADER, J. (1992). Role of phospholamban in NO/EDRF-induced relaxation in rat aorta. Lift Sciences 51, 1205-1210.
20. KOMALAVILAS, P. & LINCOLN, T. M. (1994). Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. Journal of Biological Chemistry 269, 8701-8707.
21. KOMALAVILAS, P. & LINCOLN, T. N. (1996). Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. Journal of Biological Chemistry 271, 21933-21938.
22. LINCOLN, T. M., CORNWELL, T. L., KOMALAVILAS, P., MACMILLANCROW, L. A. & BOERTH, N. (1996). The nitric oxide-cyclic GMP signaling system. In Biochemistry of Smooth Muscle Contraction, ed. BARANY, M., pp. 257-268. Academic Press, San-Diego.
23. MACKENZIE, A. B., MAHAUT-SMITH, M. P. & SAGE, S. O. (1996). Activation of receptor-operated cation channel via P2X1 not P2T purinoceptors in human platelets. Journal of Biological Chemistry 271, 2879-2881.
24. MAURICE, D. H. & HASLAM, R. J. (1990). Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Molecular Pharmacology 37, 671-681.
25. MONCADA, S., PALMER, R. M. J. & HIGGS, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43, 109-142.
26. MORO, M. A., RUSSEL, R. J., CELLEK, S., LIZASOAIN, I., Su, Y., DARLEY-USMAR, V. M., RADOMSKI, M. W. & MONCADA, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proceedings of the National Academy of Sciences of the USA 93, 1480-1485.
27. 2+ flux in reconstituted lipid vesicles. Journal of Biological Chemistry 269, 6735-6742.
28. NGUYEN, B. L., SAITON, M. & WARE, J. A. (1991). Interaction of nitric oxide and cGMP with signal transduction in activated platelets. American Journal of Physiology 261, H1043-1051.
29. 2+ release from platelet internal membranes is regulated by differential phosphorylation. Biochemistry 35, 6865-6871.
30. RADOMSKI, M. W., PALMER, R. M. J. & MONCADA, S. (1987). The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. British Journal of Pharmacology 92, 639-646.
31. STAMLER, J. S., SINGEL, D. & LOSCALZO, J. (1992). Biochemistry of nitric oxide and its redox-activated forms. Nature 258, 1898-1902.
32. SUPATTAPONE, S., DANOFF, S., THEIBERT, A., JOSEPH, S. K., STEINER, J. & SNYDER, S. H. (1988). Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proceedings of the National Academy of Sciences of the USA 85, 8747-8750.
33. i waves in rat megakaryocytes. Cell Calcium 21, 331-344.
34. 2+ release by cAMP-dependent protein kinase in a living cell. Proceedings of the National Academy of Sciences of the USA 95, 1613-1617.
35. UNEYAMA, C, UNEYAMA, H. & AKAIKE, N. (1993). Cytoplasmic calcium oscillation in rat megakaryocytes evoked by a novel type of purinoceptor. Journal of Physiology 470, 731-749.
36. WALTER, U., EIGENTHALER, M., GEIGER, J. & REINHARD, M. (1993). Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets. In Mechanisms of Platelet Activation and Control, ed. AUTHI, K. S., WATSON, S. P. & KAKKAR, V. V., pp. 237-249. Plenum Press, New York.
37. WHITTLE, B. J., MONCADA, S., WHITING, F. & VANE, J. R. (1980). Carbacyclin - a potent stable prostacyclin analogue for the inhibition of platelet aggregation. Prostaglandins 19, 605-627.
38. WISE, H. & JONES, R. L. (1996). Focus on prostacyclin and its novel mimetics. Trends in Pharmacological Sciences 17, 17-21.
39. YAN, X., LAWRENCE, D. S., CORBIN, J. D. & FRANCIS, S. H. (1996). Distinguishing between closely related protein kinases: a variation on the bisubstrate inhibitor theme. Journal of the American Chemical Society 118, 6321-6322.
40. YIN, K., LAI, P.-S., RODRIGUEZ, A, SPUR, B. W. & WONG, P. Y.-K. (1995). Antithrombotic effect of peroxynitrite: inhibition and reversal of aggregation in human platelets. Prostaglandins 50, 169-178.